New Data on the Clinical Impact of Exercise Training, Fish Oils, and Statins in Heart Failure

References

• . Thom T, Haase N, Rosamond W, . Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113(6):e85–e151
   PubMed Web of Science ®Google Scholar
• . Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease—risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53(21):1925–1932
   PubMed Web of Science ®Google Scholar
• . Din-Dzietham R, Liu Y, Bielo MV, Shamsa F. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation. 2007;116(13):1488–1496
   PubMed Web of Science ®Google Scholar
• . Johansen H, Strauss B, Arnold JM, Moe G, Liu P. On the rise: the current and projected future burden of congestive heart failure hospitalization in Canada. Can J Cardiol. 2003;19(4):430–435
   PubMed Web of Science ®Google Scholar
• . Yusuf S, Hawken S, Ounpuu S, . Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–952
   PubMed Web of Science ®Google Scholar
• . Schappert SM, Burt CW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001–02. Vital Health Stat 13. 2006;159:1–66
   PubMedGoogle Scholar
• . O'Connor CM, Whellan DJ, Lee KL, . Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301(14):1439–1450
   PubMed Web of Science ®Google Scholar
• . Keteyian SJ, Miller NH, O'Connor CM, et al; on behalf of HF-ACTION. A dose-response analysis of patients with heart failure enrolled in a controlled trial investigating outcomes of exercise training (HF-ACTION). Paper presented at: American College of Cardiology Scientific Sessions; Orlando, FL; March 29–21, 2009
   Google Scholar
• . Tavazzi L, Maggioni AP, Marchioli R, ; GISSI-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9645):1223–1230
   PubMed Web of Science ®Google Scholar
• . Kjekshus J, Apetrei E, Barrios V, et al; CORONA Group. Rosuvastatin in older patients with systolic heart failure. N Engl J Med. 2007;357(22):2248–2261
   PubMed Web of Science ®Google Scholar
• . Tavazzi L, Maggioni AP, Marchioli R, et al; Gissi-HF Investigators. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9645):1231–1239
   PubMed Web of Science ®Google Scholar
• . Thompson PD, Buchner D, Pina IL, . Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation. 2003;107(24):3109–3116
   PubMed Web of Science ®Google Scholar
• . US Department of Health and Human Services. Physical activity and health: a report of the surgeon general. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 1996
   Google Scholar
• . Lavie CJ, Thomas RJ, Squires RW, Allison TG, Milani RV. Exercise training and cardiac rehabilitation in primary and secondary coronary prevention. Mayo Clin Proc. 2009;84(4):373–383
   PubMed Web of Science ®Google Scholar
• . Artham SM, Lavie CJ, Milani RV, Chi YW, Goldman CK. Benefits of exercise training in secondary prevention of coronary and peripheral arterial disease. Vasc Dis Prev. 2008;5(3):156–168
   Google Scholar
• . Artham SM, Lavie CJ, McMullan PW. Major recent trials in cardiovascular diseases. Postgrad Med. 2009;121(2):15–24
   PubMed Web of Science ®Google Scholar
• . McKelvie RS. Exercise training in patients with heart failure: clinical outcomes, safety, and indications. Heart Fail Rev. 2008;13(1):3–11
   PubMed Web of Science ®Google Scholar
• . Smart N, Marwick TH. Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am J Med. 2004;116(10):693–706
   PubMed Web of Science ®Google Scholar
• . Piepoli MF, Davos C, Francis DP, Coats AJ; ExTraMATCH Collaborative. Exercise training meta-analysis of trials with chronic heart failure (ExTraMATCH). BMJ. 2004;328(7433):189
   PubMed Web of Science ®Google Scholar
• . Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyunsaturated fatty acids and cardiovascular diseases—a fish tale with growing credibility. In press. J Am Coll Cardiol.
   Google Scholar
• . Lee JH, O'Keefe JH, Lavie CJ, Marchioli R, Harris WS. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc. 2008;83(3):324–332
   PubMed Web of Science ®Google Scholar
• . Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312(19):1205–1209
   PubMed Web of Science ®Google Scholar
• . Albert CM, Hennekens CH, O'Donnell CJ, . Fish consumption and risk of sudden cardiac death. JAMA. 1998;279:23–28
   PubMed Web of Science ®Google Scholar
• . Burr ML Fehily AM, Gilbert JF, . Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2(8666):757–761
   PubMed Web of Science ®Google Scholar
• . Marchioli R, Barzi F, Bomba E, et al; GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105(16):1897–1903
   PubMed Web of Science ®Google Scholar
• . Yokoyama M, Origasa H, Matsuzaki M, . Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369(9567):1090–1098
   PubMed Web of Science ®Google Scholar
• . Anand RG, Alkadri M, Lavie CJ, Milani RV. The role of fish oil in arrhythmia prevention. J Cardiopulm Rehabil Prev. 2008;28(2):92–98
   PubMed Web of Science ®Google Scholar
• . O'Keefe JH Jr, Abuissa H, Sastre A, Steinhaus DM, Harris WS. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate viability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol. 2006;97(8):1127–1130
   PubMed Web of Science ®Google Scholar
• . Mozaffarian D, Bryson CL, Lemaitre RN, Burke GL, Siscovick DS. Fish intake and risk of incident heart failure. J Am Coll Cardiol. 2005;45(12):2015–2021
   PubMed Web of Science ®Google Scholar
• . Yamagishi K, Nettleton JA, Folsom AR. Plasma fatty acid composition and incident heart failure in middle-aged adults: the atherosclerosis risk in communities (ARIC) study. Am Heart J. 2008;56(5):965–974
   Google Scholar
• . Yamagishi K, Iso H, Date C, et al; Japan Collaborative Cohort Study for Evaluation of Cancer Risk Study Group. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women. J Am Coll Cardiol. 2008;52(12):988–996
   PubMed Web of Science ®Google Scholar
• . Mehra MR, Lavie CJ, Ventura HO, Milani RV. Fish oils produce anti-inflammatory effects and improved body weight in severe heart failure. J Heart Lung Transplant. 2006;25(7):834–838
   PubMed Web of Science ®Google Scholar
• . Fonarow GC. Statins and n-3 fatty acid supplementation in heart failure. Lancet. 2008;372(9645):1195–1196
   PubMed Web of Science ®Google Scholar
• . Thomas TR, Liu Y, Linden MA, Rector RS. Interaction of exercise training and n-3 fatty acid supplementation on postprandial lipemia. Appl Physiol Nutr Metab. 2007;32(3)473–480
   PubMed Web of Science ®Google Scholar
• . Smith BK, Sun GY, Donahue OM, Thomas TR. Exercise plus n-3 fatty acids: additive effect on postprandial lipemia. Metabolism. 2004;53(10):1365–1371
   PubMed Web of Science ®Google Scholar
• . Lavie CJ, Mehra MR. Statins and advanced heart failure—alive but barely breathing after CORONA and GISSI-HF. In press. Congest Heart Fail.
   Google Scholar
• . Horwich TB, MacLellan WR, Fonarow GC. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J Am Coll Cardiol. 2004;43(4):642–648
   PubMed Web of Science ®Google Scholar
• . Ramasubbu K, Estep J, White DL, Deswal A, Mann DL. Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J Am Coll Cardiol. 2008;51(4):415–426
   PubMed Web of Science ®Google Scholar
• . Khush KK, Waters DD, Bittner V, . Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study. Circulation. 2007;115(5):576–583
   PubMed Web of Science ®Google Scholar
• . Mehra MR, Uber PA. Statins and chronic heart failure: a failed hypothesis? In: Mehra MR, ed. Clinical Challenges in Heart Failure. Oxford, United Kingdom: Clinical Publishing Ltd; 2009
   Google Scholar
• . Mehra, MR, Uber PA, Lavie CJ, Milani RV, Park MH, Ventura HO. High density lipoprotein cholesterol levels and prognosis in advanced heart failure. In press. J Heart Lung Transplant.
   Google Scholar